Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Carcinoma, Ovarian Epithelial × fluzoparib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Ovarian Epithelial 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2 pembrolizumab 1 lenvatinib 1 fluzoparib 1 apatinib 1 Surgical Procedures, Operative 1 Quality of Life 1 Paclitaxel 1 Nutritional Status 1 Neoadjuvant Therapy 1 Interviews as Topic 1 Drug Therapy 1 Diagnostic Imaging 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06539091 2024-08-06

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Anhui Provincial Hospital

Phase 3 Not yet recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡